Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Gilenya's Price | Main | More On Cancer Drug Shortages »

August 8, 2011

Read the Comments

Email This Entry

Posted by Derek

Just wanted to point out to anyone who's not reading the comments here that the ones to this post are of extremely high quality. If you want to hear the thoughts of a lot of intelligent, experienced people on what's wrong with the drug industry and what might be done to fix it, have a look.

Comments (9) + TrackBacks (0) | Category: Drug Industry History


COMMENTS

1. Frodo on August 8, 2011 12:16 PM writes...

Don't jinx yourself, Derek. True, your blog has a very intelligent and eloquent following. Evil trolls are everywhere on the Internet, though.

I am not a chemist, but I enjoy reading your blog every day. You need to get going on a book. I'll buy it.

Permalink to Comment

2. Student on August 8, 2011 12:51 PM writes...

Unfortunately this begs the question if any influential decision makers read this blog and if they consider yourself and your followers opinions worthy of considering.

Permalink to Comment

3. CMCguy on August 8, 2011 2:34 PM writes...

Hmm.. I would actually be a bit concerned if "influential decision makers" had time to read this or any other blog. That said I trust those that do read it are both educated and stimulated so can (and willing to) offer input to those in greater influence.

"what's wrong with the drug industry" has developed over many, many years and "what might be done to fix it" is not likely going to be fast solutions either and well could have negative impact on Chemists/Science employment (although Munos' call for "cut R&D" is not that simplistic as more advocate reduction/elimination of certain types to focus toward high potential "breakthroughs".

Permalink to Comment

4. Vladimir Chupakhin on August 8, 2011 3:24 PM writes...

Honestly, I'm reading the blog mostly because of the comments!

Permalink to Comment

5. Rick on August 8, 2011 6:22 PM writes...

CMC guy, #3
""what's wrong with the drug industry" has developed over many, many years" I'd add it's developed into a cottage industry of its own over these many, many years. As with the hedge fund industry and waste management, there's money to be made in failures and garbage. Actually fixing the problems with the system would be bad for business!

Permalink to Comment

6. Foolseverywhere on August 8, 2011 6:45 PM writes...

What was intelligent about it?

A banking shill, Bernard Munos, spreading lies to a bunch of dum dum scientists that the "industry will collapse!!" unless they work for nothing.

Guess what dum dum scientists: does the insolvent banking system ever collapse? Funny how in all those freshly minted trillion dollars handed to dead banks, you poor peasants called scientists can't manage to scrape out a dime to your name. Meanwhile Banker Exhibit A hands himself a 100 million dollar bonus for managing a dead bank....boy you guys need Derek to keep you real dumb.

Permalink to Comment

7. cliffintokyo on August 9, 2011 3:18 AM writes...

#6 Absolutely on the money! (sic)
I have packed up and left science.
See UK news: scientists don't do rampage.
Your post should be a 'caveat emptor' handout for all potential student science majors.
After all, most people prefer to be a parasite than to work for a subsistence wage.
Has *Bankster A* got the message? Does he care? (Hint: Rhetorical Questions)

Permalink to Comment

8. Rick on August 9, 2011 9:09 AM writes...

Interesting and relevant article in today's NY Times Science Times section on efforts to recruit more scientist into the political arena. http://www.nytimes.com/2011/08/09/science/09emily.html?ref=science Same thing could be said for getting scientists into top executive & board positions in pharma and biotech as well as into education.

Permalink to Comment

9. MoMo on August 9, 2011 4:48 PM writes...

Dont lose sleep #6, as some of us dumb scientists stick our thumbs in the eyes of management and guys like you every day. Its the wizards like us that sign the patents on useful compounds, ones made without upper management approval or even knowledge. But they sure like them! Ca - ching!

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
A Last Summer Day Off
The Early FDA
Drug Repurposing
The Smallest Drugs
Life Is Too Short For Some Journal Feeds
A New Look at Phenotypic Screening
Small Molecules - Really, Really Small
InterMune Bought